Literature DB >> 21057086

The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells.

Kazuko Miyazaki1, Masaki Miyazaki, Yun Guo, Norimasa Yamasaki, Masamoto Kanno, Zen-ichiro Honda, Hideaki Oda, Hiroshi Kawamoto, Hiroaki Honda.   

Abstract

Naturally occurring regulatory T (Treg) cells play a central role in the maintenance of immune homeostasis and in restraining the development of spontaneous inflammatory responses. However, the underlying mechanisms of Treg homeostasis remain incompletely understood. Of particular note, the IL-2Rα (CD25) is crucial for the homeostasis of Treg cells and the prevention of lymphoproliferative autoimmune disease. In this paper, we report that the basic helix-loop-helix transcription factor Dec1 is involved in the homeostasis of Treg cells and plays a role in their survival or expansion after adoptive transfer to lymphopenic recipients. Hence, it is crucial for the suppression of effector T cell-mediated inflammatory responses. Enforced expression of Dec1 upregulates CD25 expression during thymocyte development and increases the number of Treg cells in the periphery. Dec1 binds the transcription factor Runx1 and colocalizes with Runx1 in Treg cells. Specifically, we demonstrate that in Treg cells the Dec1/Runx1 complex binds to regulatory elements present in the Il-2rα locus. Collectively, these data show how Dec1 mechanistically acts in Treg cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057086     DOI: 10.4049/jimmunol.1001381

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  The DNA methylation profile of activated human natural killer cells.

Authors:  John K Wiencke; Rondi Butler; George Hsuang; Melissa Eliot; Stephanie Kim; Manuel A Sepulveda; Derick Siegel; E Andres Houseman; Karl T Kelsey
Journal:  Epigenetics       Date:  2016-03-11       Impact factor: 4.528

Review 2.  Transcription Factor Bhlhe40 in Immunity and Autoimmunity.

Authors:  Melissa E Cook; Nicholas N Jarjour; Chih-Chung Lin; Brian T Edelson
Journal:  Trends Immunol       Date:  2020-10-07       Impact factor: 16.687

3.  Regulation of B-1a cells: another novel function of the basic helix-loop-helix transcriptional regulator BHLHE41.

Authors:  Buka Samten
Journal:  Cell Mol Immunol       Date:  2017-09-04       Impact factor: 11.530

Review 4.  Homeostatic control of regulatory T cell diversity.

Authors:  Adrian Liston; Daniel H D Gray
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

5.  DEC1 deficiency results in accelerated osteopenia through enhanced DKK1 activity and attenuated PI3KCA/Akt/GSK3β signaling.

Authors:  Shuangcheng He; Yu Guan; Yichen Wu; Ling Zhu; Bingfang Yan; Hiroaki Honda; Jian Yang; Wei Liu
Journal:  Metabolism       Date:  2021-02-17       Impact factor: 8.694

6.  BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy.

Authors:  Avery J Salmon; Alexander S Shavkunov; Qi Miao; Nicholas N Jarjour; Sunita Keshari; Ekaterina Esaulova; Charmelle D Williams; Jeffrey P Ward; Anna M Highsmith; Josué E Pineda; Reshma Taneja; Ken Chen; Brian T Edelson; Matthew M Gubin
Journal:  Cancer Immunol Res       Date:  2022-05-03       Impact factor: 12.020

7.  Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.

Authors:  Masatoshi Kanda; Hiroyuki Yamanaka; Satoshi Kojo; Yuu Usui; Hiroaki Honda; Yusuke Sotomaru; Michishige Harada; Masaru Taniguchi; Nao Suzuki; Tatsuya Atsumi; Haruka Wada; Muhammad Baghdadi; Ken-Ichiro Seino
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

8.  Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease.

Authors:  Masaki Miyazaki; Kazuko Miyazaki; Shuwen Chen; Manami Itoi; Marina Miller; Li-Fan Lu; Nissi Varki; Aaron N Chang; David H Broide; Cornelis Murre
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

9.  Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.

Authors:  Clint Piper; Vivian Zhou; Richard Komorowski; Aniko Szabo; Benjamin Vincent; Jonathan Serody; Maria-Luisa Alegre; Brian T Edelson; Reshma Taneja; William R Drobyski
Journal:  Blood       Date:  2020-02-20       Impact factor: 22.113

10.  SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest.

Authors:  Yaju Wang; Vinay Kumar Rao; Wai Kay Kok; Dijendra Nath Roy; Sumita Sethi; Belinda Mei Tze Ling; Martin Beng Huat Lee; Reshma Taneja
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.